Clinical Research Hub
Live Research Database

Eczema
Hub: San Antonio, TX

Connecting patients in San Antonio with breakthrough clinical trials, specialized care, and study-related compensation.

User
User
User
User
+4k
Join 4,200+ participants tracking trials in Texas

Available Eczema Opportunities

12 Recruiting
NCT06807268(Verify)

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

RECRUITING
Eczema
NCT07003425(Verify)

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

RECRUITING
Eczema
NCT07006792(Verify)

A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

RECRUITING
Eczema
NCT05995964(Verify)

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

RECRUITING
Eczema
NCT06947993(Verify)

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

RECRUITING
Eczema
NCT07230860(Verify)

A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis

RECRUITING
Eczema
NCT06863961(Verify)

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

RECRUITING
Eczema
NCT07150845(Verify)

Phase 2b Study of EVO756 in Adults With Atopic Dermatitis

RECRUITING
Eczema
NCT07217015(Verify)

A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis

RECRUITING
Eczema
NCT06461897(Verify)

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

RECRUITING
Eczema
NCT07298395(Verify)

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

RECRUITING
Eczema
NCT07105488(Verify)

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

RECRUITING
Eczema

Patient Safeguards

IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks

"Advancing Eczema research in San Antonio through safe, transparent, and patient-first clinical trials."

ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT